BioDelivery Sciences International, Inc.
BDSI
BDSI was delisted on the 22nd of March, 2022.
147 hedge funds and large institutions have $252M invested in BioDelivery Sciences International, Inc. in 2020 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 43 increasing their positions, 61 reducing their positions, and 20 closing their positions.
50% more call options, than puts
Call options by funds: $1.04M | Put options by funds: $693K
7% less funds holding
Funds holding: 158 → 147 (-11)
18% less capital invested
Capital invested by funds: $309M → $252M (-$56.9M)
30% less repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 61
50% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 20
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$4.64M |
| 2 |
SFM
Systematic Financial Management
Teaneck,
New Jersey
|
+$2.78M |
| 3 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$2.56M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$1.05M |
| 5 |
BCI
Brinker Capital Investments
Berwyn,
Pennsylvania
|
+$924K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACA
Avoro Capital Advisors
New York
|
-$8.87M |
| 2 |
EP
Eversept Partners
New York
|
-$2.54M |
| 3 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$1.92M |
| 4 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$1.58M |
| 5 |
BlackRock
New York
|
-$1.41M |
BDSI Hedge Fund Activity: Q3 2020 in Review
147 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q3 2020, worth a combined $252M — down 18% from $309M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of BDSI and 10 opened new positions — a net loss of 10 holders — while 61 trimmed existing stakes and 43 added.
The largest buyer was Deerfield Management, adding an estimated $4.64M. The largest seller was Avoro Capital Advisors, exiting entirely with an estimated $8.87M sold.
- 147 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q3 2020, down from 158 in Q2 2020.
- Funds reported $252M of BioDelivery Sciences International, Inc. stock for Q3 2020, down 18% quarter-over-quarter.
- 10 funds opened new BioDelivery Sciences International, Inc. positions in Q3 2020 and 20 closed out, a net change of -10 holders.
- The largest BioDelivery Sciences International, Inc. buyer in Q3 2020 was Deerfield Management, an estimated $4.64M added.
- The largest BioDelivery Sciences International, Inc. seller in Q3 2020 was Avoro Capital Advisors, an estimated $8.87M sold.
Based on aggregated 13F filings for Q3 2020.